Psychedelic drugs reconsidered: by Lester Grinspoon and James B. Bakalar, published by Basic Books, New York; xiv + 343 pp.

Abstract

Hallucinogens are drugs that alter consciousness by distorting primarily auditory and visual perception but can affect any sensory system. Hallucinogens also affect judgment, orientation, memory, and emotions. Despite profound alterations in perception, adverse effects are minimal and hallucinogens are not addictive. Hallucinogen use has its roots in shamanic practices of indigenous cultures and is even incorporated in today's religions like the Native American church. By putting a person in an altered state of consciousness, many religions believed that the user was able to see beyond the boundaries of reality and reach out to mythical beings. Hallucinogen use in scientific research was not popular until the 1950s when Albert Hoffman discovered lysergic acid diethylamide (LSD). The discovery of the drug encouraged further research into understanding its mechanisms and its relationship with mental diseases like schizophrenia. Unfortunately, the Comprehensive Drug Abuse Prevention and Control Act of 1970 significantly limited hallucinogenic research and human research for 42 years before 2012. However, animal research between 1990 and 2010 has determined the importance of serotonergic mechanisms and more specifically the 5-HT2A receptors in mediating LSD's hallucinogenic effects. Researchers continue to identify mechanisms of LSD action through additional receptors such as dopaminergic and metabotropic glutamate receptors. Positron emission tomography scans and functional magnetic resonance imaging have also revealed the importance of the prefrontal cortical region and its interaction with other areas during a hallucinogenic state. Although human clinical research is limited, recent research sees a much deeper relationship by linking LSD brain activity and neurotransmitter levels to psychotic behaviors. The relationship between LSD and acute psychosis is being explored via animal models. Further understanding of hallucinogens on a physiological and psychological level has led to possible psychotherapeutic areas of research in anxiety and substance abuse. This chapter describes a brief history of hallucinogenic research, the pharmacology and neuroanatomy of serotonergic hallucinogens, the acute and chronic adverse effects of serotonergic hallucinogens, the possible treatments for complications with hallucinogenic use, the epidemiology, the relationship between hallucinogens and schizophrenia, and possible therapeutic uses of serotonergic hallucinogens.